Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jan 2014

Kerr Sarah E, Schnabel Catherine A, Sullivan Peggy S, Zhang Yi, Huang Vivian J, Erlander Mark G, Brachtel Elena F, Dry Sarah M

Abstract excerpt

A diagnosis of neuroendocrine carcinoma is often morphologically straight-forward; however, the tumor site of origin may remain elusive in a metastatic presentation. Neuroendocrine tumor subtyping has important implications for staging and patient management. In this study, the novel use and performance of a 92-gene molecular cancer classifier for determination of the site of tumor origin are described in a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to Neoplasms, Unknown Primary

Share to Neuroendocrine Tumors

Share to Predictive Value of Tests

Share to Reproducibility of Results

Share to United States

Source

Identifiers

PMID: 23846576
DOI: 10.1038/modpathol.2013.105

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors.PMID 23846576Read ↗

Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implicationsSemantic proximity Read ↗

Pathologic Classification of Neuroendocrine Neoplasms.Semantic proximity Read ↗

Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patientsSemantic proximity Read ↗

Genome Methylation Accurately Predicts Neuroendocrine Tumor Origin: An Online ToolSemantic proximity Read ↗

Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.Semantic proximity Read ↗

Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.Semantic proximity Read ↗

Gene Expression Profiling for the Diagnosis of Multiple Primary Malignant TumorsSemantic proximity Read ↗

Gene expression profiling for the diagnosis of multiple primary malignant tumorsSemantic proximity Read ↗

The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in BloodSemantic proximity Read ↗

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinomaSemantic proximity Read ↗

Multicenter Validation of a 1,550-Gene Expression Profile for Identification of Tumor Tissue of OriginSemantic proximity Read ↗

Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.